Sarcosine as a potential prostate cancer biomarker and therapeutic target
Cancer Biol Ther
.
2010 Mar 1;9(5):341-2.
doi: 10.4161/cbt.9.5.11310.
Epub 2010 Mar 26.
Authors
Caitlin E Baum
1
,
Douglas K Price
,
William D Figg
Affiliation
1
Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
PMID:
20150759
PMCID:
PMC2874119
DOI:
10.4161/cbt.9.5.11310
No abstract available
MeSH terms
Biomarkers, Tumor / urine*
Humans
Male
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / metabolism
Prostatic Neoplasms* / therapy
Sarcosine / metabolism*
Substances
Biomarkers, Tumor
Sarcosine
Grants and funding
NIH0012636439/ImNIH/Intramural NIH HHS/United States
NIH0012636439/PHS HHS/United States